CONMED Corporation
CNMD
$34.03
-$0.74-2.13%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.39% | 485.48% | -86.65% | 254.89% | -82.12% |
| Total Depreciation and Amortization | 6.73% | -5.14% | 0.19% | 1.74% | 9.92% |
| Total Amortization of Deferred Charges | -53.41% | 114.66% | -8.07% | -3.81% | -49.26% |
| Total Other Non-Cash Items | -84.77% | 162.46% | 86.62% | -66.04% | 8.20% |
| Change in Net Operating Assets | -51.73% | -175.12% | 222.61% | -2,835.38% | 102.66% |
| Cash from Operations | -70.92% | -13.69% | 84.27% | -29.86% | -4.16% |
| Capital Expenditure | 43.42% | 1.47% | 9.46% | -51.60% | 6.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Investing | 157.77% | -37.09% | 9.46% | -95.60% | 27.50% |
| Total Debt Issued | -3.74% | 11.98% | -16.78% | 20.88% | 10.67% |
| Total Debt Repaid | 25.12% | -5.61% | 7.40% | -17.21% | 2.91% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -0.03% | -0.05% | -0.10% | -0.05% |
| Other Financing Activities | 5.75% | -34.11% | 10.77% | -22.44% | 14.20% |
| Cash from Financing | 39.65% | 14.14% | -64.08% | 6.59% | 44.39% |
| Foreign Exchange rate Adjustments | -2,494.12% | 70.00% | -98.73% | 91.94% | 136.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -406.51% | -62.19% | 422.19% | -114.06% | 178.71% |